Editorial: Purinergic signalling in the central nervous system and its pharmacological importance in neurological and psychiatric illnesses

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Contributors

Yong Tang: URI : https://loop.frontiersin.org/people/563292/overviewRole: Role: Role: Role:

Patrizia Rubini: URI : https://loop.frontiersin.org/people/1914685/overviewRole: Role: Role: Role:

Beata Sperlagh: URI : https://loop.frontiersin.org/people/425012/overviewRole: Role: Role:

Henning Ulrich: URI : https://loop.frontiersin.org/people/446563/overviewRole: Role: Role:

Journal

Journal ID (nlm-ta): Front Pharmacol

Journal ID (iso-abbrev): Front Pharmacol

Journal ID (publisher-id): Front. Pharmacol.

Title: Frontiers in Pharmacology

Publisher: Frontiers Media S.A.

ISSN (Electronic): 1663-9812

Publication date (Electronic): 12 January 2024

Publication date Collection: 2023

Volume: 14

Electronic Location Identifier: 1355286

Affiliations

[1] ¹ International Joint Research Centre on Purinergic Signalling , Chengdu, China

[2] ² Acupuncture and Chronobiology Key Laboratory of Sichuan Province , School of Health and Rehabilitation , Chengdu University of Traditional Chinese Medicine , Chengdu, China

[3] ³ Laboratory of Molecular Pharmacology , HUN-REN Institute of Experimental Medicine , Budapest, Hungary

[4] ⁴ Department of Biochemistry , Institute of Chemistry , University of Sao Paulo , Sao Paulo, Brazil

Author notes

Edited and reviewed by: Filippo Drago, University of Catania, Italy

*Correspondence: Yong Tang, tangyong@ 123456cdutcm.edu.cn

Article

Publisher ID: 1355286

DOI: 10.3389/fphar.2023.1355286

PMC ID: 10811060

PubMed ID: 38283840

SO-VID: 19ad045c-fd8d-4ec8-bd4b-32c7c6244400

License:

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

History

Date received : 13 December 2023

Date accepted : 31 December 2023

Funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. NSFC-RSF (82261138557), NSFC (82274668, 82230127), the Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine (ZYYCXTD-D-202003), the Sichuan Science and Technology Program (2022YFH0006), Sichuan Provincial Administration of Traditional Chinese Medicine (2023zd024), the São Paulo Research Foundation (FAPESP 2018/07366-4), and National Council for Scientific and Technological Development (CNPq, Brasília) (406396/2021-3).

Custom metadata

section-at-acceptance Experimental Pharmacology and Drug Discovery

ScienceOpen disciplines: Pharmacology & Pharmaceutical medicine

Keywords: purinergic signalling,central nervous system,neurological and psychiatric illnesses,atp,p1,p2,adenosine

Data availability:

ScienceOpen disciplines: Pharmacology & Pharmaceutical medicine

Keywords: purinergic signalling, central nervous system, neurological and psychiatric illnesses, atp, p1, p2, adenosine

Comments

Comment on this article

scite_